
A Two-Dose Approach Could Enhance HIV Vaccine Efficacy
MIT researchers have demonstrated that a two-dose HIV vaccine regimen, administered a week apart, can elicit a robust immune response comparable to a multi-dose approach. This discovery holds promise for developing more practical and effective HIV vaccines for widespread use.